Buy Laurus Labs: target of Rs 450: Sharekhan
Sharekhan is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 450 in its research report dated March 10, 2021.
March 12, 2021 / 08:57 AM IST
Sharekhan's research report on Laurus Labs
Formulations business on a strong footing to grow backed by opportunities in the US while diversification to non ARV areas – anti diabetics and cardiology to fuel API growth. Sturdy growth prospects, visibility on earnings, healthy return ratios and low debt-equity are the key positives. Over a long term horizon of 3-5 years, Laurus has charted out its growth trajectory encompassing all segments & management aspires grow its revenues beyond $1bn in size.
We retain a Buy recommendation on Laurus Labs Limited (Laurus) with a revised PT of Rs. 450.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.